Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Suven Life Sciences Plunges 5%; BSE HEALTHCARE Index Down 0.2%
Tue, 17 Sep 10:58

Suven Life Sciences Plunges 5%; BSE HEALTHCARE Index Down 0.2%Image source: StarLineArts/www.istockphoto.com

Suven Life Sciences share price has plunged 5% and is presently trading at Rs 155.8.

Meanwhile, the BSE HEALTHCARE index is at 44,289.3 (down 0.2%).

Among the top losers in the BSE HEALTHCARE index today are Biocon (down 2.4%) and KIMS (down 2.2%).

ALEMBIC PHARMA (up 1.6%) and Divis Laboratories (up 1.0%) are among the top gainers today.

Over the last one year, Suven Life Sciences has moved up from Rs 78.1 to Rs 155.8, registering a gain of Rs 77.8 (up 99.6%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,434.4 to 44,289.3, registering a gain of 55.8% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 172.8%), SUVEN PHARMACEUTICALS (up 124.0%) and Glenmark Pharma (up 100.7%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 82,984.8 .

The top losers among the BSE Sensex today are Tata Motors (down 2.1%) and MUNDRA PORT & SEZ (down 1.1%). The most traded stocks in the BSE Sensex are Tata Motors and Tata Steel.

In the meantime, NSE Nifty is at 25,412.3 (up 0.1%). Hero Motocorp and Divis Laboratories are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 67,467.0 to 82,984.8, registering a gain of 15,517.8 points (up 23.0%).

Suven Life Sciences Financial Update...

Suven Life Sciences net profit fell 16.4% YoY to Rs -280 million for the quarter ended June 2024, compared to a loss of Rs 241 million a year ago. Net sales declined 73.5% to Rs 10 million during the period as against Rs 38 million in April-June 2023.

For the year ended March 2024, Suven Life Sciences reported 11.2% increase in net profit to Rs -1,051 million compared to net loss of Rs 1,183 million during FY23. Revenue of the company fell 13.6% to Rs 117 million during FY24.

The current Price to earnings ratio of Suven Life Sciences, based on rolling 12 month earnings, stands at -31.2.


Equitymaster requests your view! Post a comment on "Suven Life Sciences Plunges 5%; BSE HEALTHCARE Index Down 0.2%". Click here!